{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:20:44Z","timestamp":1784546444759,"version":"3.55.0"},"reference-count":32,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s583071","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:02:19Z","timestamp":1772557339000},"page":"1-13","source":"Crossref","is-referenced-by-count":2,"title":["Effect of Cyclosporine Ophthalmic Solution 0.09% on Signs and Symptoms of Dry Dye Disease in Patients Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%: Results from a Single-Arm, Open-Label, Phase 4 Study"],"prefix":"10.2147","volume":"Volume 20","author":[{"given":"Josh","family":"Johnston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7394-5852","authenticated-orcid":true,"given":"Michelle","family":"Hessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2937-1457","authenticated-orcid":true,"given":"Kelly","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6961-1836","authenticated-orcid":true,"given":"Bobby","family":"Saenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9036-5158","authenticated-orcid":true,"given":"Laura","family":"Periman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Truett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitee","family":"Urbieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1001\/jamaophthalmol.2022.4394","volume":"140","author":"McCann","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"109035","DOI":"10.1016\/j.exer.2022.109035","volume":"219","author":"Di Zazzo","year":"2022","journal-title":"Exp Eye Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jtos.2023.04.006","volume":"28","author":"Stapleton","year":"2023","journal-title":"Ocul Surf"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3390\/jcm14051408","volume":"14","author":"De Gregorio","year":"2025","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"ref9","unstructured":"Restasis\u00ae (Cyclosporine Ophthalmic Emulsion) 0.05%. Full Prescribing Information. Allergan; 2024."},{"key":"ref10","unstructured":"CEQUA\u00ae (Cyclosporine Ophthalmic Solution) 0.09%. Full Prescribing Information. Sun Pharmaceutical Industries. Inc.; 2022."},{"key":"ref11","unstructured":"Vevye\u00ae (Cyclosporine Ophthalmic Emulsion) 0.1%. Full Prescribing Information. Harrow Eye. 2025."},{"key":"ref12","unstructured":"Xiidra\u00ae (Lifitegrast Ophthalmic Solution) 5%. Full Prescribing Information. Shire US, Inc.; 2016."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jtos.2016.01.001","volume":"14","author":"Perez","year":"2016","journal-title":"Ocul Surf"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/archopht.120.3.330","volume":"120","author":"Kunert","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1001\/archopht.118.11.1489","volume":"118","author":"Kunert","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"ref16","first-page":"90","volume":"42","author":"Brignole","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1167\/iovs.13-11681","volume":"54","author":"Gao","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/ICO.0b013e318158f6dc","volume":"27","author":"Pflugfelder","year":"2008","journal-title":"Cornea"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/archophthalmol.2008.608","volume":"127","author":"Brown","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.clinthera.2006.11.016","volume":"28","author":"Trattler","year":"2006","journal-title":"Clin Ther"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.4.3.1","volume":"4","author":"Cholkar","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11095-018-2556-5","volume":"36","author":"Mandal","year":"2019","journal-title":"Pharm Res"},{"key":"ref23","unstructured":"Han DH. FDA approves Cequa for the treatment of dry eye disease. EMPR. 2018. Available from: https:\/\/www.empr.com\/home\/news\/fda-approves-cequa-for-the-treatment-of-dry-eye-disease\/. [Accessed October 14, 2025.]."},{"key":"ref24","unstructured":"Effect of Cequa\u2122 in subjects with dry eye disease. ClinicalTrials.gov identifier: NCT04357795. Updated February 6, 2024. Accessed October 14, 2025. https:\/\/clinicaltrials.gov\/study\/NCT04357795."},{"key":"ref25","first-page":"221","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/s1542-0124(12)70053-8","volume":"5","author":"Schaumberg","year":"2007","journal-title":"Ocul Surf"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.ophtha.2019.03.050","volume":"126","author":"Goldberg","year":"2019","journal-title":"Ophthalmology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2147\/OPTH.S175065","volume":"12","author":"Tauber","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/OPTO.S350185","volume":"15","author":"Semp","year":"2023","journal-title":"Clin Optom"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/ICO.0000000000001562","volume":"37","author":"Baenninger","year":"2018","journal-title":"Cornea"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12886-023-03174-y","volume":"23","author":"Karpecki","year":"2023","journal-title":"BMC Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jval.2014.10.007","volume":"18","author":"Blome","year":"2015","journal-title":"Value Health"}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/112668","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/112668","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:02:24Z","timestamp":1772557344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/effect-of-cyclosporine-ophthalmic-solution-009-on-signs-and-symptoms-o-peer-reviewed-fulltext-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":32,"URL":"https:\/\/doi.org\/10.2147\/opth.s583071","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}